Clinical Trial Update: Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of flutamide on biomarkers in blood and tissue from patients at high risk for ovarian cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• flutamide (flutamide)

Snippet

Sponsor: University of Arizona | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-01-05